Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
As an important enzyme in DNA synthesis, dUTPase is present in a wide variety of organisms and viruses and has been identified as a component of the equine infectious anemia virus (EIAV) pol gene. The role of EIAV dUTPase, designated DU, in virus replication in vitro and in vivo was investigated with a recently described infectious molecular clone of EIAV. A deletion mutant that was deficient in dUTPase activity was constructed, and its replication kinetics was examined in fetal equine kidney (FEK) cells and primary equine bone marrow macrophage (EBMM) cells. In FEK cells, which are permissive for EIAV replication, the mutant virus replicated as well as the parental virus. In primary cultures of EBMM cells, which are primary targets of EIAV infection in vivo, the DU mutant showed delayed replication kinetics and replicated to a lower extent than did the parental virus. As the multiplicity of infection decreased, the difference between the parental and mutant viruses increased, such that at the lowest multiplicity of infection tested, there was over a 100-fold difference in virus production. The mutant virus was also much less cytopathic. The role of DU in replication in vivo was examined using a Shetland pony model of EIAV infection. Shetland ponies that were infected with the parental and mutant viruses showed transient virus RNA levels in plasma approximately 5 to 10 days postinfection. The peak virus levels in plasma (as measured by a quantitative reverse transcriptase PCR assay) were 10- to 100-fold lower in the mutant virus-infected animals than in the animals infected with the parental virus. However, ponies infected with the mutant virus mounted similar antibody responses despite the marked differences in virus replication. These studies demonstrate that EIAV DU is important for the efficient replication of the virus in macrophages in vitro and in vivo and suggests that variations in the DU sequence could markedly affect the biological and pathogenic properties of EIAV.
Lichtenstein
D L
DL
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Rushlow
K E
KE
Cook
R F
RF
Raabe
M L
ML
Swardson
C J
CJ
Kociba
G J
GJ
Issel
C J
CJ
Montelaro
R C
RC
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D001483:Base Sequence; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral / Q000235:genetics / Q000502:physiology; D017931:DNA Primers / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics; D004859:Equine Infectious Anemia / Q000821:virology; D017353:Gene Deletion; D015751:Genes, pol; D006736:Horses; D004860:Infectious Anemia Virus, Equine / Q000201:enzymology* / Q000235:genetics* / Q000502:physiology; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011755:Pyrophosphatases / Q000172:deficiency / Q000235:genetics*; D012367:RNA, Viral / Q000097:blood / Q000235:genetics; D014779:Virus Replication / Q000235:genetics / Q000502:physiology
D000914:Antibodies, Viral; D017931:DNA Primers; D004279:DNA, Viral; D012367:RNA, Viral; D011755:Pyrophosphatases; C020020:dUTP pyrophosphatase